Gene therapy progress and prospects cancer: Oncolytic viruses

T. C. Liu; D. Kirn

doi:10.1038/gt.2008.72

Gene therapy progress and prospects cancer: Oncolytic viruses

T. C. Liu, D. Kirn

Research output: Contribution to journal › Review article › peer-review

140 Scopus citations

Abstract

The past 2 years have seen several major advances in oncolytic virotherapy. Studies on the interaction between viruses, immune responses and tumor microenvironment have provided important insight, while clinical trials have shown promise. This review summarizes key findings in this field over the past 2 years, and provides directions for future success.

Original language	English
Pages (from-to)	877-884
Number of pages	8
Journal	Gene therapy
Volume	15
Issue number	12
DOIs	https://doi.org/10.1038/gt.2008.72
State	Published - Jun 2008

Access to Document

10.1038/gt.2008.72

Cite this

@article{1cf818d8df444474a57aae43373ae7ed,

title = "Gene therapy progress and prospects cancer: Oncolytic viruses",

abstract = "The past 2 years have seen several major advances in oncolytic virotherapy. Studies on the interaction between viruses, immune responses and tumor microenvironment have provided important insight, while clinical trials have shown promise. This review summarizes key findings in this field over the past 2 years, and provides directions for future success.",

author = "Liu, {T. C.} and D. Kirn",

year = "2008",

month = jun,

doi = "10.1038/gt.2008.72",

language = "English",

volume = "15",

pages = "877--884",

journal = "Gene therapy",

issn = "0969-7128",

number = "12",

}

TY - JOUR

T1 - Gene therapy progress and prospects cancer

T2 - Oncolytic viruses

AU - Liu, T. C.

AU - Kirn, D.

PY - 2008/6

Y1 - 2008/6

N2 - The past 2 years have seen several major advances in oncolytic virotherapy. Studies on the interaction between viruses, immune responses and tumor microenvironment have provided important insight, while clinical trials have shown promise. This review summarizes key findings in this field over the past 2 years, and provides directions for future success.

AB - The past 2 years have seen several major advances in oncolytic virotherapy. Studies on the interaction between viruses, immune responses and tumor microenvironment have provided important insight, while clinical trials have shown promise. This review summarizes key findings in this field over the past 2 years, and provides directions for future success.

UR - http://www.scopus.com/inward/record.url?scp=44849135037&partnerID=8YFLogxK

U2 - 10.1038/gt.2008.72

DO - 10.1038/gt.2008.72

M3 - Review article

C2 - 18418413

AN - SCOPUS:44849135037

SN - 0969-7128

VL - 15

SP - 877

EP - 884

JO - Gene therapy

JF - Gene therapy

IS - 12

ER -

Gene therapy progress and prospects cancer: Oncolytic viruses

Abstract

Access to Document

Other files and links

Fingerprint

Cite this